Clinical Trial Update: Phase II-b Randomized Clinical Trial of Cabazitaxel in Metastatic Colorectal Cancer Resistant to Standard Treatment [Phase 2]

View source ↗

Summary

A Phase II-b randomized trial of cabazitaxel in metastatic colorectal cancer resistant to standard treatment was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Jevtana (cabazitaxel)

Snippet

Sponsor: Hospital Clinico Universitario de Santiago | Conditions: Colorectal Cancer | Phase 2 | Status: TERMINATED